Table 1—

Baseline characteristics of the EURODLAB PCS population

nTotal CHD+Total CHDMen CHD+Men CHDWomen CHD+Women CHD
n1512,178691,133821,045
Age (years)2,32938.1 ± 10.531.7 ± 9.537.4 ± 10.531.8 ± 9.538.6 ± 10.631.6 ± 9.5
Diabetes duration (years)2,32819.0 ± 10.314.0 ± 8.817.9 ± 10.513.7 ± 8.719.9 ± 10.114.3 ± 9.0
GHb (%)2,3136.85 ± 1.636.63 ± 1.886.98 ± 1.656.57 ± 1.846.74 ± 1.616.69 ± 1.91
Systolic BP (mmHg)2,321126.9 ± 19.9119.7 ± 16.5127.6 ± 21.4122.4 ± 16.0126.2 ± 18.7116.8 ± 16.5
Diastolic BP (mmHg)2,32175.0 ± 11.875.0 ± 11.275.8 ± 12.376.2 ± 11.274.4 ± 11.373.7 ± 11.0
Cholesterol (mg/dl)2,303214.2 ± 46.3204.8 ± 43.3208.4 ± 47.4200.0 ± 42.6219.2 ± 45.1210.1 ± 43.4
LDL cholesterol (mg/dl)1,545136.0 ± 41.9128.2 ± 37.4136.1 ± 44.0127.0 ± 36.6136.8 ± 40.9129.8 ± 38.9
HDL cholesterol (mg/dl)2,28856.2 ± 17.058.2 ± 16.550.7 ± 13.953.6 ± 14.961.0 ± 18.163.2 ± 16.8
Non-HDL cholesterol (mg/dl)2,288158.0 ± 47.4146.6 ± 43.8157.6 ± 49.6146.3 ± 43.0158.2 ± 45.8146.8 ± 44.7
FTG (mg/dl)1,56593.8 (65.2–135.7)79.5 (60.7–110.7)100.4 (69.2–143.3)83.0 (62.5–118.8)85.7 (63.4–133.0)76.8 (58.9–100.0)
Waist circumference (cm)2,31881.6 ± 10.179.4 ± 9.486.6 ± 8.583.2 ± 8.777.4 ± 9.475.3 ± 8.5
WHR2,3180.86 ± 0.100.84 ± 0.100.92 ± 0.070.88 ± 0.080.82 ± 0.100.80 ± 0.10
BMI (kg/m2)2,31223.9 ± 2.923.5 ± 2.824.3 ± 2.823.6 ± 2.623.6 ± 3.023.3 ± 2.9
AER (μg/min)2,22520.2 (8.6–87.9)10.7 (6.5–21.9)35.9 (9.1–278.2)11.3 (6.8–25.4)15.7 (8.5–81.4)10.1 (6.2–19.8)
Insulin dose (units • day−1 • kg−1)2,2900.64 (0.53–0.77)0.67 (0.54–0.81)0.67 (0.53–0.79)0.66 (0.54–0.81)0.62 (0.53–0.76)0.67 (0.55–0.82)
No. of insulin injections/day2,3252.37 ± 0.682.58 ± 0.752.32 ± 0.742.54 ± 0.742.41 ± 0.632.62 ± 0.76
Hypertension (yes)2,32934 (51)21 (450)35 (24)23 (256)33 (27)19 (194)
BP-lowering drugs (yes)2,31618 (27)7.5 (162)20 (14)7.7 (87)16 (13)7.2 (75)
Lipid-lowering drugs (yes)2,3222.7 (4)1.2 (27)4 (3)1.4 (16)1.2 (1)1.1 (11)
Current smoking2,32235 (52)31 (667)43 (30)33 (369)27 (22)29 (298)
Exsmoking2,32217 (25)18 (389)22 (15)21 (242)12 (10)14 (147)
Retinopathy*1,91964 (74)44 (790)62 (36)46 (435)67 (38)41 (355)
Neuropathy2,28446 (69)31 (653)51 (35)31 (343)41 (34)30 (310)
Autonomic neuropathy2,16238 (53)28 (557)43 (27)27 (277)35 (26)29 (280)
Microalbuminuria2,22531 (44)20 (427)33 (20)22 (241)30 (24)19 (186)
Macroalbuminuria2,22519 (27)7.0 (145)26 (16)7.7 (83)14 (11)6 (62)
  • Data are means ± SD, median (interquartile range), or % (n).

  • *

    * Nonproliferative and proliferative retinopathy.